Related Experiment Videos
Chrysotherapy: pharmacological and clinical correlates.
The Journal of Rheumatology
|December 11, 1975
Summary
Higher serum gold levels, above 300 mug per cent, prolonged therapeutic response in rheumatoid arthritis (RA) patients undergoing chrysotherapy. Pharmacokinetic principles can optimize gold accessibility and treatment effectiveness.
Area of Science:
- Rheumatology
- Clinical Pharmacology
Background:
- Chrysotherapy, a treatment for rheumatoid arthritis (RA), involves gold administration.
- Serum gold concentrations can fluctuate widely despite standard dosing.
Purpose of the Study:
- To investigate the relationship between gold administration, serum gold levels, and therapeutic response in RA patients.
- To explore pharmacokinetic principles for optimizing chrysotherapy.
Main Methods:
- Observational study of 56 RA subjects over five years of weekly chrysotherapy.
- Monitoring of serum gold content and clinical/laboratory responses.
- Individual dosage adjustments based on patient serum gold levels.
Main Results:
- Significant fluctuations in serum gold levels were observed.
- Higher sustained serum gold concentrations (greater than 300 mug per cent) correlated with prolonged enhanced clinical and laboratory response.
- Maintaining higher serum levels may improve gold access to deeper body compartments.
Conclusions:
- Pharmacokinetic principles are crucial for optimizing chrysotherapy.
- Achieving and maintaining serum gold levels above 300 mug per cent is important for sustained therapeutic effects in RA.
- Individualized dosing based on serum gold monitoring can enhance treatment efficacy.